Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

Today, 2:39 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

1 minute read

IMV Q2 EPS $(0.11) Down From $(0.08) YoY, Sales $42.00K Up From $40.00K YoY

By Benzinga Newsdesk

Today, 2:39 PM

IMV (NASDAQ:IMV) reported quarterly losses of $(0.11) per share. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $42.00 thousand in sales this

IMV

11 minute read

Earnings Scheduled For August 11, 2021

By Benzinga Insights

Today, 2:39 PM

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.

ACVA

1 minute read

IMV’s Shares Jump As Ovarian Cancer Candidate Shows Overall Survival Rate Of 44.9%

By Vandana Singh

Today, 2:39 PM

IMV Inc (NASDAQ:IMV) has announced the final topline results of the DeCidE1 Phase 2 trial evaluating maveropepimut-S (MVP-S, formerly known as…

IMV

2 minute read

FDA
News

IMV Inc. Reports Final Topline Results From DeCidE1 Trial In Advanced Recurrent Ovarian Cancer

By Benzinga Newsdesk

Today, 2:39 PM

Final patient completed the study after more than 2 years of clinical benefits with maveropepimut-S (MVP-S) Median Overall Survival was 19.9 months, and overall survival rate was 44.9% at 23.8 months Translational

IMV

2 minute read

IMV Announces Final Topline Results Of DeCidE1 Clinical Trial In Advanced Recurrent Ovarian Cancer; Says ‘Median Overall Survival was 19.9 months, and overall survival rate was 44.9% at 23.8 months’

By Bill Haddad

Today, 2:39 PM

IMV

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 2:39 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

5 minute read

48 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 2:39 PM

Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The stock is also trading higher in sympathy with the price of Bitcoin.

ABEO